William Lee
Director/Board Member at Amygdala Neurosciences, Inc.
Profile
Currently, William A. Lee is Executive Vice President-Research at Gilead Sciences, Inc. He is also on the board of Molecular Partners AG and Amygdala Neurosciences, Inc. and Member of Elevation 6000, LLC. Dr. Lee previously was Research Scientist at Syntex Corp. and Head-Drug Delivery & Formulation at California Biotechnology, Inc. He received a doctorate from the University of California San Diego and an undergraduate degree from the University of Massachusetts.
William Lee active positions
Companies | Position | Start |
---|---|---|
Elevation 6000, LLC
Elevation 6000, LLC Real Estate DevelopmentFinance Elevation 6000, LLC provides real estate brokerage services. | Corporate Officer/Principal | - |
Amygdala Neurosciences, Inc.
Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Director/Board Member | - |
Former positions of William Lee
Companies | Position | End |
---|---|---|
GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2021-04-11 |
MOLECULAR PARTNERS AG | Director/Board Member | 2020-04-28 |
California Biotechnology, Inc. | Corporate Officer/Principal | 1990-12-31 |
Syntex Corp. | Corporate Officer/Principal | - |
Training of William Lee
University of California San Diego | Doctorate Degree |
University of Massachusetts | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
MOLECULAR PARTNERS AG | Health Technology |
Private companies | 4 |
---|---|
Syntex Corp. | Health Technology |
California Biotechnology, Inc. | Health Technology |
Amygdala Neurosciences, Inc.
Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Health Technology |
Elevation 6000, LLC
Elevation 6000, LLC Real Estate DevelopmentFinance Elevation 6000, LLC provides real estate brokerage services. | Finance |
- Stock Market
- Insiders
- William Lee